市場調查報告書
商品編碼
1423014
2024-2032 年按產品類型(眼科黏彈性裝置、人工水晶體、飛秒雷射、超音波乳化設備等)、最終用途和地區分列的白內障手術器械市場報告Cataract Surgical Devices Market Report by Product Type (Ophthalmic viscoelastic devices, Intraocular lenses, Femtosecond laser, Phacoemulsification equipment, and Others), End-Use, and Region 2024-2032 |
2023年全球白內障手術器械市場規模達89億美元。展望未來, IMARC Group預計到2032年市場規模將達到124億美元,2024-2032年複合年成長率(CAGR)為3.7%。白內障病例數量的不斷增加、飛秒雷射和超音波乳化系統等先進設備的引入、全球醫療保健支出的不斷成長以及醫療保健服務的改善是推動市場發展的一些關鍵因素。
白內障手術器械是指白內障手術期間使用的一系列專用儀器和設備,白內障手術是一種常見的外科手術,用於從眼睛中摘除渾濁的晶狀體(白內障)並用人工晶狀體(IOL)替換。白內障會導致視力障礙甚至失明,而白內障手術是恢復視力、提升患者生活品質的有效方法。白內障手術器械在確保以最小的風險和改善的結果成功進行白內障手術方面發揮著至關重要的作用。科技的進步促進了複雜設備的發展,徹底改變了白內障手術,使其成為全球最常見和最成功的外科手術之一。
在行業的幾個關鍵促進因素和趨勢的推動下,市場正在經歷顯著成長。白內障手術設備的技術進步在推動市場成長方面發揮了關鍵作用。飛秒雷射輔助白內障手術和先進人工水晶體材料等創新提高了手術精度,帶來更好的結果和更快的患者康復時間。此外,人們對眼睛健康意識的增強和先進治療方案的可用性正在影響患者的偏好。現在,患者更願意在病情早期接受白內障手術,以維持生活品質和視力。因此,對高品質白內障手術的需求不斷成長,推動了白內障手術設備的市場成長。此外,亞洲、拉丁美洲和非洲的新興經濟體對白內障手術設備的需求正在激增,這主要是由於醫療基礎設施的改善、可支配收入的增加以及人們對眼睛健康意識的增強。隨著醫療保健設施的改善,越來越多的患者尋求白內障手術,促進了全球市場的擴張。
白內障盛行率不斷上升,老年人口不斷增加
全球人口老化是影響市場的主要因素之一。隨著年齡的成長,罹患白內障的風險顯著增加。白內障是一種常見的與年齡相關的眼部疾病,其特徵是眼睛的自然水晶體混濁,導致視力模糊和視力下降。隨著世界人口的壽命比以往任何時候都長,被診斷出患有白內障的人數正在增加。因此,對白內障手術和相關手術設備的需求不斷成長。老年人尋求有效且安全的治療方案以恢復視力並提高整體生活品質。這種人口結構的變化刺激了製造商在研發方面的大量投資,從而推出了先進的白內障手術設備,這些設備可以提供更好的結果、更短的恢復時間並提高患者滿意度。
各種技術進步
白內障手術設備的持續技術進步和創新徹底改變了眼科領域。這些創新在推動市場成長方面發揮了關鍵作用。製造商不斷探索新材料、設計和手術技術,以提高白內障手術的效率和安全性。一項重大進步是飛秒雷射輔助白內障手術 (FLACS) 的引入,它在手術過程中提供精確且可重複的切口。 FLACS 使外科醫生能夠以更高的準確性執行白內障手術的各個步驟,最大限度地降低併發症的風險並改善視力結果。此外,優質人工水晶體(IOL)的開發擴大了白內障患者的治療選擇。高級人工水晶體具有多焦點、擴展焦深和散光矯正等功能,使患者無需依賴眼鏡即可在不同距離獲得清晰的視力。
新興經濟體的需求不斷增加
新興經濟體對白內障手術器械的需求不斷成長是影響市場的另一個重要因素。隨著亞洲、拉丁美洲和非洲國家醫療基礎設施的改善和可支配收入的增加,白內障手術的可近性也增加。隨著人們對眼睛健康的認知不斷提高以及醫療設施的普及,越來越多的人正在尋求白內障治療。此外,這些地區的政府和醫療機構正在積極推動眼部健康措施並提供白內障手術補貼,以解決白內障引起的視力障礙的負擔。這種積極主動的方法不僅增加了手術數量,還促進了先進白內障手術設備的採用。
The global cataract surgical devices market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The growing number of cataract cases, the introduction of sophisticated devices, such as femtosecond lasers and phacoemulsification systems, the growing global healthcare expenditure and the improved access to healthcare services represent some of the key factors driving the market.
Cataract surgical devices refer to a range of specialized instruments and equipment used during cataract surgery, a common surgical procedure to remove a cloudy lens (cataract) from the eye and replace it with an artificial intraocular lens (IOL). Cataracts can cause vision impairment or blindness, and cataract surgery is an effective method to restore vision and improve the quality of life for patients. Cataract surgical devices play a vital role in ensuring successful cataract surgeries with minimal risk and improved outcomes. Advances in technology have led to the development of sophisticated devices that have revolutionized cataract surgery, making it one of the most common and successful surgical procedures globally.
The market is experiencing significant growth, driven by several key drivers and trends in the industry. Technological advancements in cataract surgical devices have played a pivotal role in propelling market growth. Innovations such as femtosecond laser-assisted cataract surgery and advanced IOL materials have improved surgical precision, leading to better outcomes and quicker patient recovery times. Moreover, the increasing awareness of eye health and the availability of advanced treatment options are influencing patient preferences. Patients are now more willing to undergo cataract surgery at an earlier stage of the condition to maintain their quality of life and visual acuity. Consequently, the rising demand for high-quality cataract surgical procedures is bolstering the market growth of cataract surgical devices. Besides, the emerging economies in Asia, Latin America, and Africa are witnessing a surge in demand for cataract surgical devices, primarily due to improving healthcare infrastructure, rising disposable incomes, and growing awareness about eye health. As access to healthcare facilities improves, a larger patient pool seeks cataract surgery, contributing to the expansion of the global market.
Growing prevalence of cataract and rising geriatric population
The aging global population is one of the primary factors impacting the market. As people age, the risk of developing cataracts increases significantly. Cataracts are a common age-related eye condition characterized by the clouding of the eye's natural lens, leading to blurred vision and decreased visual acuity. With the world's population living longer than ever before, the number of individuals diagnosed with cataracts is on the rise. As a result, there is a growing demand for cataract surgeries and related surgical devices. The elderly population seeks effective and safe treatment options to restore their vision and improve their overall quality of life. This demographic shift has spurred significant investments in research and development by manufacturers, leading to the introduction of advanced cataract surgical devices that offer better outcomes, shorter recovery times, and enhanced patient satisfaction.
Various technological advancements
Continuous technological advancements and innovations in cataract surgical devices have revolutionized the field of ophthalmology. These innovations have played a pivotal role in driving market growth. Manufacturers are constantly exploring new materials, designs, and surgical techniques to enhance the efficiency and safety of cataract surgeries. One significant advancement is the introduction of femtosecond laser-assisted cataract surgery (FLACS), which provides precise and reproducible incisions during the procedure. FLACS enables the surgeon to perform various steps of cataract surgery with increased accuracy, minimizing the risk of complications and improving visual outcomes. Additionally, the development of premium intraocular lenses (IOLs) has expanded treatment options for cataract patients. Premium IOLs offer features such as multifocality, extended depth of focus, and astigmatism correction, allowing patients to achieve clear vision at different distances without relying on glasses.
Increasing demand in emerging economies
The growing demand for cataract surgical devices in emerging economies is another significant factor influencing the market. As healthcare infrastructure improves and disposable incomes rise in countries across Asia, Latin America, and Africa, the accessibility of cataract surgeries has increased. With greater awareness of eye health and improved access to medical facilities, more individuals are seeking treatment for cataracts. Furthermore, governments and healthcare organizations in these regions are actively promoting eye health initiatives and offering subsidized cataract surgeries to tackle the burden of visual impairment caused by cataracts. This proactive approach has not only boosted the number of surgeries performed but also fostered the adoption of advanced cataract surgical devices.
IMARC Group provides an analysis of the key trends in each segment of the global cataract surgical devices market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type and end-use.
Ophthalmic viscoelastic devices (OVDs)
Intraocular lenses (IOLs)
Femtosecond laser
Phacoemulsification equipment
Others
Intraocular lenses represent the most popular product type
The report has provided a detailed breakup and analysis of the market based on the product type. This includes ophthalmic viscoelastic devices (OVDS), intraocular lenses (IOLs), femtosecond laser, phacoemulsification equipment, and others. According to the report, intraocular lenses represented the largest segment.
Intraocular lenses are a crucial component of cataract surgery, as they play a pivotal role in restoring vision after the cloudy natural lens has been removed. Cataracts cause significant visual impairment, and IOLs offer an effective and reliable solution to replace the clouded lens with an artificial one, allowing patients to regain clear vision. Moreover, the field of intraocular lenses has witnessed significant technological advancements over the years. Manufacturers have continually improved the design and materials used in IOLs to enhance optical performance and patient comfort. For example, the introduction of multifocal and extended depth of focus IOLs allows individuals to achieve clear vision at various distances, reducing the reliance on glasses post-surgery.
Hospitals
Eye care clinics
Eye Treatment and Surgical Centres
Hospitals hold the largest market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, eye care clinics, and eye treatment and surgical centers. According to the report, hospitals hold the largest market share.
Hospitals are equipped with advanced surgical facilities and a skilled team of ophthalmic surgeons who specialize in cataract surgery. Cataract surgery is a delicate procedure that requires precision and expertise, and hospitals are well-equipped to provide the necessary resources and personnel to perform these surgeries effectively. Moreover, hospitals offer comprehensive eye care services, making them a go-to choice for patients seeking cataract treatment. From pre-operative evaluations and diagnostics to post-operative follow-ups, hospitals provide all-inclusive care, ensuring the best possible outcomes for patients undergoing cataract surgery. Apart from this, many ophthalmologists and eye care specialists practice in hospitals. These professionals refer patients with cataracts to their affiliated hospitals for surgical procedures, further boosting the hospitals' market share in the market.
Europe
North America
Latin America
Asia Pacific
Middle East and Africa
North America accounts for the majority of market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States, has a significant aging population. With age being a primary risk factor for cataracts, the region experiences a higher prevalence of cataract cases. As a result, there is a substantial demand for cataract surgeries and related surgical devices, driving the market share in the region. Besides, North America boasts a well-developed and advanced healthcare infrastructure with a wide network of hospitals, ambulatory surgical centers (ASCs), and specialty eye clinics. This infrastructure facilitates easy access to cataract surgeries, making them more readily available to patients. The availability of state-of-the-art medical facilities and skilled ophthalmic surgeons contributes to the region's higher market share.
The competitive landscape of the market is characterized by the presence of several established medical device companies, along with emerging players, striving to gain a foothold in the industry. Nowadays, key players are offering a wide array of cataract surgical devices, including different types of intraocular lenses (IOLs) with varying features (multifocal, toric, and accommodating), phacoemulsification systems, and other surgical instruments. They are also expanding their market presence by entering new geographic regions and establishing partnerships with local distributors and healthcare facilities. Besides, to maintain credibility and gain the trust of patients and healthcare providers, key players are ensuring strict adherence to international regulatory standards and obtain necessary certifications for their products.
Abbott Laboratories
Hoya Corporation
Carl Zeiss Meditec AG
Alcon Laboratories Inc.
Essilor International S.A.
In January 2021, Alcon launched AcrySof IQ Vivity, the first and only non-diffractive extended depth of focus intraocular lens in the United States to demonstrate their ongoing commitment to growing IOL portfolio and delivering differentiated innovations that meet surgeon and patient needs.
In October 2020, HOYA Surgical Optics announces global launch of CLEARlog - an app designed to analyze clinical outcomes of Cataract and RLE surgery. It is an app that allows surgeons to record and analyze their cataract and RLE practice patterns.
Carl Zeiss Meditec acquired IanTECH for an undisclosed amount. The acquisition strengthened Carl Zeiss' position in the cataract surgery portfolio as IanTECH focuses on technology solutions for micro-interventional cataract surgery.